Access Control in the Pharmaceutical Sector

Pharma plants have many serious security concerns

  • Multi-level, hierarchical access rights
  • Campus-style locations in large science parks
  • Need for visual recognition checks at key access points
  • Dangerous chemicals
  • Minimum and maximum number of people to be in sensitive ares
  • Time-of-day access restrictions
  • Activist infiltration and sabotage
  • Industrial espionage
  • Multi-billion dollar intelectual property rights
  • Clean room security
  • Airborne contaminants
  • Strict muster and evacuation regulations
  • Portable, very high value inventory
  • Daily access-logging for prescription drugs

ACT solutions for the pharmacuetical sector

  • Easily managed hierarchical access rights - ACTenterprise software, with zones controlled by our contactless smart cards, keypads and biomentric readers, allows central control over access to areas of varying sensitivity,
  • Face recognition - ACTenterprise instantly shows the person's features to the security guard at the entrance.
  • Risk-appropriate security levels - ACT contactless smart cards in standard areas; ACT digital keypads or biometric identification for more sensitive areas. ACT’s DESFire EV1 cards are ideal for high security applications - the 128bit AES encryption ensures that the data is not compromised during transmission.
  • Numbers present control - ACT systems can ensure that access is granted only when the minimum number of people are at the door, and access is refused when the maximum number has been reached.
  • Muster control for evacuationsACTenterprise software creates muster reports for a fire or spillage event, enabling a roll call at muster points to identify staff who have not checked in.
  • Random challenge command - arbitrary selection of people for bag search where there is access to high value prescription or opiate drugs. Avoids any accusation of bias or descrimination in the selection process.
  • Drug access audit trail - ACTenterprise pro allows users to demonstrate full compliance with United States’ Food and Drug Administration's requirement (21 CFR Part 11) for daily documentation of staff members who have access to large quantities of prescription medication.


  • Pharmaceutical chemical production plants
  • Final dosage form and packaging lines
  • Biopharma plants
  • Diagnostic product development and production facilities
  • Medical research laboratories
  • Drug production units
  • Clinical trial locations

Speak to ACT about your Needs Today Contact Us